This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hansen, L. Search for Related Content PubMed PubMed Citation Articles by Hansen, L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB FLUOXETINE Social Bookmarking                         What's this?

Fluoxetine Dose-Increment Related Akathisia in Depression: Implications for Clinical Care, Recognition and Management of Selective Serotonin Reuptake Inhibitor-Induced Akathisia

Department of Psychiatry, Royal South Hants, Southampton, UK.lh4{at}soton.ac.uk

We report the case of a 22-year-old woman presenting major depressive episode with severe akathisia after an increase in fluoxetine. The patient developed severe restlessness andde novosuicidal ideation approximately 1 week after the dosage of fluoxetine was doubled, 1 year on from when the drug was first introduced. This case illustrates the importance of being alert to movement disorders in patients treated with selective serotonin reuptake inhibitors. The clinical implications are discussed. A management strategy based on the evidence in the existing literature is suggested.

Key Words: akathisia • depression • fluoxetine • selective serotonin reuptake inhibitors • suicidality

Journal of Psychopharmacology, Vol. 17, No. 4, 451-452 (2003)
DOI: 10.1177/0269881103174003


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?